Researchers at Florida State University have discovered that certain gut bacteria, such as Klebsiella pneumoniae, can migrate ...

Osaka Metropolitan University researchers have found that administering the dried seeds of a type of jujube called Ziziphus ...

Alzheimer’s Society is continuing work on the Blood Biomarker Challenge, a project that could bring dementia blood tests to the NHS within five years. Blood-based biomarkers could be the ...

The only approved treatments for Alzheimer’s disease are medications with limited effectiveness and a risk of severe, sometimes deadly, side effects. That’s why scientists search for therapies ...

Dementia comes in different forms—the most common form is Alzheimer's disease—and is characterized by an impaired ability to remember, think and make decisions. Today, there is no known cure ...

Credit: SciTechDaily.com Researchers have discovered that methazolamide, a glaucoma drug, can clear tau protein build-up in the brain, a key factor in dementias like Alzheimer’s. This study, using ...

As the world of neurodegenerative disease drug development continues to be roiled by controversies, one company has taken a different, noninvasive approach to treating Alzheimer’s disease.

If you’re an unhappy voter and want other unhappy voters to hold their noses and vote for the major candidate they least dislike, think about the Golden Rule.

Early data suggest Roche’s antibody may safely and quickly remove amyloid plaque for patients with Alzheimer’s disease, though the midstage study has been tied to one death. The interim data ...

driven by ongoing cost-cutting measures and the strong performance of its new Alzheimer’s treatment. The biotech company now expects 2024 adjusted per-share earnings in the range of between $16. ...

A new study has used powerful imaging to reveal a subset of Alzheimer's-associated proteins spreading particularly rapidly. These 'superspreaders' may help explain why abnormal clumps of the naturally ...